Shattuck Labs Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Shattuck Labs Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- STTK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001680367
- EIN
- 81-2575858
Board of directors
-
Amy Kate Sasser · DirectorSince 2024
-
Carrie Brownstein · DirectorSince 2023
-
Clay B. Siegall · DirectorSince 2024
-
Daniel G. Baker · DirectorSince 2025
-
George Golumbeski · DirectorSince 2023
-
Helen M. Boudreau · DirectorSince 2023
-
Jeremy Green · DirectorSince 2023
-
Michael Stewart Lee · DirectorSince 2023
-
Mona Ashiya · DirectorSince 2025
-
Neil W. Gibson · DirectorSince 2023
-
Taylor Schreiber · Director · Chief Executive OfficerSince 2023
-
Tyler Brous · DirectorSince 2023
Chief executives
Taylor Schreiber
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.4%
-
93.0%
-
94.7%
Board connections
8 of this board's directors also sit on 11 other boards.
- via Jeremy Green and Michael Stewart Lee
- via Jeremy Green
- via George Golumbeski
- via Daniel G. Baker
- via Jeremy Green
- via Mona Ashiya
- via Clay B. Siegall
- via Neil W. Gibson
- via Helen M. Boudreau
- via Helen M. Boudreau
- via Mona Ashiya
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $250,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $591,850
- 6 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Option exercise | +12,153 | $3.57 | $43,386 |
| Jul 2, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Option exercise | +410 | $3.57 | $1,464 |
| Jul 2, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Open-market sale | −410 | $7.01 | $2,874 |
| Jul 1, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Option exercise | +100 | $3.57 | $357 |
| Jul 1, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Open-market sale | −100 | $7.07 | $707 |
| Jun 30, 2026 | Pandite Arundathy N. Officer (Chief Medical Officer) | Open-market sale | −30,000 | $7.01 | $210,300 |
| Jun 30, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Option exercise | +23,365 | $3.57 | $83,413 |
| Jun 30, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Open-market sale | −23,365 | $7.08 | $165,424 |
| Jun 9, 2026 | Clay B. Siegall Director | Open-market purchase | +62,500 | $4.00 | $250,000 |
| May 22, 2026 | Clay B. Siegall Director | Grant or award | +128,054 | $1.08 | $138,298 |
| May 21, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Grant or award | +5,122 | $1.08 | $5,532 |
| May 15, 2026 | Stout Stephen Officer (See Remarks) | Grant or award | +12,805 | $1.08 | $13,829 |
| May 12, 2026 | Neill Andrew R Officer (Chief Financial Officer) | Grant or award | +64,027 | $1.08 | $69,149 |
| May 12, 2026 | Shukla Abhinav A. Officer (Chief Technical Officer) | Option exercise | +2,032 | $3.57 | $7,254 |
| May 12, 2026 | Pandite Arundathy N. Officer (Chief Medical Officer) | Open-market sale | −30,000 | $6.61 | $198,300 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.